HomeAI · summaries
Storia in 17 fonti
Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
- ·
biopharmadive.com
‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically tough-to-treat tumor.
- ·
huffingtonpost.it
La scienza ha trovato come colpire il tumore "impossibile". La cura del cancro al pancreas a un punto di svolta (di L.Varlese)
Per la prima volta un farmaco sperimentale contro la proteina KRAS mostra risultati concreti contro il tumore al pancreas. Sopravvivenza quasi raddoppiata nei …
- ·
nbcnews.com
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
- ·
independent.co.uk
Daily pill almost doubles survival time for pancreatic cancer patients in new trial
Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease
- ·
theguardian.com
Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer
- ·
dailymail.com
New drug gives extra months of life to pancreatic cancer patients
Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.
- ·
Experimental pill promises new hope for deadly pancreatic cancer
New research shows a novel pill is helping people with advanced pancreatic cancer live longer
- ·
Pancreatic cancer breakthrough as pill almost doubles survival time for patients
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…
- ·
cbsnews.com
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
- ·
fortune.com
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…
- ·
cnn.com
Experimental pill promises new hope for deadly pancreatic cancer | CNN
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…
- ·
dailysabah.com
Experimental pill offers breakthrough hope in pancreatic cancer fight
An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...
- ·
inews.co.uk
Why this new pill for a deadly cancer has doctors excited
The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer
- ·
Experimental drug shows promise against deadly pancreatic cancer
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…
- ·
calabria7.news
Tumore al pancreas, svolta dalla ricerca: il farmaco daraxonrasib raddoppia la sopravvivenza (Calabria 7)
Un nuovo studio clinico sta attirando grande attenzione nella comunità scientifica internazionale per i risultati ottenuti nel trattamento del tumore al
- ·
nature.com
Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments
Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumours will be next.
- ·
sciencedaily.com
Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most…
- ·
sciencealert.com
Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers
WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of…
- ·
benzinga.com
Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits
Few cancers have proven as difficult to treat as pancreatic cancer, making any sign of a survival breakthrough a major event for both patients and investors.